nOPV 2 Vaccine
- Recently WHO has listed the nOPV2 vaccine (manufactured by Bio Farma, Indonesia) for emergency use to address the rising cases of a vaccine-derived polio strain in a number of African and East Mediterranean countries. Countries in WHO’s Western Pacific and South-East Asia regions are also affected by these outbreaks.
- It is the first ever vaccine listed under WHO emergency use. The emergency use listing, or EUL, is the first of its kind for a vaccine and paves the way for potential listing of COVID-19 vaccines.
- The world has made incredible progress toward polio eradication, reducing polio cases by 99.9% in the last ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
News Snippets
- 1 Sea Otters Help Restore Ecosystem Balance
- 2 Lion-Tailed Macaque Faces Growing Threats
- 3 ICJ Hearings on States’ Legal Obligations to Combat Climate Change
- 4 GenCast AI Model Revolutionizes Weather Forecasting
- 5 Shockwave-based Syringe for Needle-Free, Painless Drug Delivery
- 6 Willow Chip: Google's Quantum Computing Breakthrough
- 7 Indian Researchers use AI to Discover Anti-Ageing Molecules
- 8 India-UK 2+2 Foreign and Defence Dialogue
- 9 India-Kuwait Joint Commission for Cooperation
- 10 India & EU to Hold Strategic Foreign Policy Dialogue
